Metabolic Reset & Weight Optimization in Los Angeles

Patients who tend to benefit most include those with insulin resistance, metabolic syndrome, prediabetes, PCOS, or persistent weight gain that has not responded to diet and lifestyle changes alone. Those who have experienced significant weight regain after previous loss, or who carry excess visceral fat disproportionate to overall body weight, are also frequently strong candidates. A thorough metabolic evaluation determines the most appropriate treatment path for each individual.

Tirzepatide is FDA-approved under the brand names Mounjaro for type 2 diabetes management and Zepbound for chronic weight management in adults. Retatrutide's regulatory status is an evolving area, and Dr. Lalezar will provide current information during your consultation. Any therapy prescribed at Health & Vitality Center is administered under close medical supervision with a full discussion of its regulatory status, risks, and alternatives.

Gastrointestinal symptoms are the most commonly reported, including nausea, bloating, constipation, or diarrhea, particularly during the initial phase or with dose increases. These typically diminish as the body adjusts. Less common but more serious effects can include changes in heart rate, gallbladder-related issues, and pancreatitis, which is why individual risk assessment and ongoing monitoring are integral to these protocols.

A comprehensive baseline evaluation typically includes fasting glucose, fasting insulin, HbA1c, thyroid function, sex hormone panels, inflammatory markers, liver function, and a lipid panel. This data identifies the specific metabolic dysfunctions contributing to weight gain and guides selection of the therapies most likely to be effective for your individual biology.

Yes. Peptide therapies are most effective when supported by appropriate nutritional strategies, physical activity, and sleep optimization. Dr. Lalezar incorporates dietary and lifestyle guidance into each patient's protocol, with the expectation that treatment makes those changes more sustainable by reducing appetite dysregulation and correcting the hormonal imbalances that often make lifestyle efforts feel ineffective.

Duration depends on individual health goals and metabolic response. Some patients continue therapy long-term as part of an ongoing metabolic health strategy, while others taper as markers normalize and weight stabilizes at a healthy level. Dr. Lalezar revisits this throughout the program based on your progress and evolving goals.

Discontinuing GLP-1 or GIP receptor agonist therapy can allow appetite signals and metabolic patterns to reassert themselves over time, which may lead to weight regain if durable lifestyle changes have not been established. This is why Dr. Lalezar's approach integrates dietary and lifestyle support alongside pharmacotherapy, with the goal of building long-term metabolic resilience rather than indefinite medication dependence.

Yes. Restoring insulin sensitivity and reducing metabolic inflammation has benefits across multiple systems. Patients may experience improvements in blood sugar regulation, cardiovascular risk markers, PCOS symptoms, energy, sleep quality, and hormonal balance. For some patients, metabolic optimization rather than weight loss alone is the primary objective.

Health & Vitality Center operates as a private-pay practice. Coverage for GLP-1 and GIP receptor agonist medications varies by insurance plan and the diagnosis associated with the prescription. The team can help patients understand what may be reimbursable through their individual provider.

Progress is tracked through lab testing, symptom review, and physical measurements at regular intervals. Biomarkers such as fasting insulin, glucose, HbA1c, and inflammatory markers help assess metabolic response beyond weight alone. Dr. Lalezar uses this data to refine dosing and adjust the protocol as your physiology responds over time.